Fig. 4
From: Indel detection from DNA and RNA sequencing data with transIndel
Indel detection on whole exome sequencing (WES) data. a The size distribution of detected indels (≥ 10 bp) by transIndel and the reported indels in the TCGA and AACR-PCF-SU2C studies for primary and metastatic castration-resistant prostate cancer, respectively. b Venn diagram of medium- and large-sized indels (≥ 10 bp) called by original TCGA and AACR-PCF-SU2C studies versus transIndel. c transIndel identified novel deletions in FOXA1 from ten prostate cancer specimens that were missed by original TCGA study (lower panel)